Prevalencia de mosaicismo para la trisomía 21 y análisis de las variantes citogenéticas en pacientes con diagnóstico de síndrome de Down: Revisión de 24 años (1986-2010) del Servicio de Genética del Hospital General de México ''Dr. Eduardo Liceaga''

Background. Down syndrome is the principal genetic cause of learning disabilities, with an incidence of 1/650 live births. Diagnosis is confi rmed by karyotyping. Chromosomal variants are important for genetic counseling. We determined the prevalence of cytogenetic variants in patients with clinically diagnosed Down syndrome in the Hospital General de Mexico Dr. Eduardo Liceaga and discussed its relevance according to maternal age. Methods. We reviewed karyotype data of patients with clinically diagnosed Down syndrome from January 1986 to December 2010 and obtained maternal and patient ages. Results. From 581 patients analyzed, 71 (12.22%) had normal karyotype. In 510 patients we confi rmed that 445 (87.3%) had a regular trisomy, 22 (6.3%) were the product of a Robertsonian translocation and mosaicism was found in 43 (8.4%) patients. Maternal age was higher in patients with regular trisomy (median: 30 years) and mosaicism (median: 29 years) than in those with translocations (median: 20 years). Conclusions. Characterization of chromosomal aberrations in Mexican Down syndrome patients allows us to offer appropriate genetic counseling and to establish the prevalence of mosaicism in our population, which was higher than the reported data. Cytogenetic analysis for detection of mosaicism is important in patients with scarce clinical data of Down syndrome or with learning disabilities of unknown origin.

[1]  Peter Delves,et al.  Encyclopedia of life sciences , 2009 .

[2]  K. Ghosh,et al.  Incidence of down syndrome: Hypotheses and reality , 2011, Indian journal of human genetics.

[3]  Y. Yurov,et al.  Chromosomal mosaicism goes global , 2008, Molecular Cytogenetics.

[4]  E. Haan,et al.  Epidemiology of Down syndrome in South Australia, 1960-89. , 1991, American journal of human genetics.

[5]  D. Harris,et al.  Parental trisomy 21 mosaicism. , 1982, American journal of human genetics.

[6]  P. Nallasivam,et al.  Cytogenetic Evaluation of Down Syndrome: A Review of 1020 Referral Cases , 2010 .

[7]  S. Girirajan Parental-age effects in Down syndrome , 2009, Journal of Genetics.

[8]  M. Desai,et al.  Cytogenetic analysis of Down syndrome in Gujarat. , 2007, Indian pediatrics.

[9]  P. P. Reddy,et al.  Cytogenetic studies of 1001 Down syndrome cases from Andhra Pradesh, India. , 2000, The Indian journal of medical research.

[10]  E. Hook,et al.  Cytogenetic and epidemiological findings in Down syndrome, England and Wales 1989 to 1993. National Down Syndrome Cytogenetic Register and the Association of Clinical Cytogeneticists. , 1996, Journal of medical genetics.

[11]  S. Frías,et al.  Detection of mosaicism in lymphocytes of parents of free trisomy 21 offspring. , 2002, Mutation research.

[12]  E. Iwarsson,et al.  On the origin of trisomy 21 Down syndrome , 2008, Molecular Cytogenetics.

[13]  S. Rajangam,et al.  Cytogenetic investigations in Down syndrome patients & their parents. , 1992, The Indian journal of medical research.

[14]  P. Morrison,et al.  Accuracy of the clinical diagnosis of Down syndrome. , 2004, The Ulster medical journal.

[15]  Mokhtar Mm,et al.  Cytogenetic profile of Down syndrome in Alexandria, Egypt. , 2003 .

[16]  L. Eaves,et al.  The phenotype of persons having mosaicism for trisomy 21/Down syndrome reflects the percentage of trisomic cells present in different tissues , 2009, American journal of medical genetics. Part A.

[17]  B. Zilfalil,et al.  Cytogenetic and clinical profile of Down syndrome in Northeast Malaysia. , 2007, Singapore medical journal.

[18]  A. Nordgren,et al.  Germinal and Somatic Trisomy 21 Mosaicism: How Common is it, What are the Implications for Individual Carriers and How Does it Come About? , 2010, Current genomics.